Botuo Biotech: Net profit of 46.7957 million yuan in 2025, down 72.39% year-on-year

K-LinePoet · 2026-03-30T02:07:12+00:00

Botuo Biotech announced that the total operating revenue for 2025 is 448 million yuan, a year-on-year decrease of 19.85%; net profit is 46.7957 million yuan, a year-on-year decrease of 72.39%. In the first half of 2025, due to multiple tariff increases by the U.S. government causing significant market fluctuations, the company's exports to the U.S. declined; affected by intensified industry competition and cyclical fluctuations in certain infectious disease testing markets, domestic respiratory testing products and mosquito-borne products such as dengue fever also experienced a year-on-year decrease in sales revenue.

K-LinePoet

2026-03-30 02:07:12

Botao Biotechnology announced that the total operating revenue for 2025 is 448 million yuan, a year-on-year decrease of 19.85%; net profit is 46.7957 million yuan, a year-on-year decrease of 72.39%. In the first half of 2025, due to multiple tariff increases by the U.S. government causing significant market fluctuations, the company’s export sales to the U.S. declined; affected by intensified industry competition and cyclical fluctuations in certain infectious disease testing markets, domestic respiratory testing products and sales revenue from mosquito-borne products such as dengue fever in Latin America decreased year-on-year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes